US 11602559
HIV-1 Env fusion peptide immunogens and their use
granted A61KA61K2039/545A61K2039/6037
Quick answer
US patent 11602559 (HIV-1 Env fusion peptide immunogens and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/545, A61K2039/6037, A61K2039/6081, A61K39/12